BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2386196)

  • 1. Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content.
    el-Naggar AK; Batsakis JG; Teague K; Giacco G; Guinee VF; Swanson D
    Am J Pathol; 1990 Aug; 137(2):275-80. PubMed ID: 2386196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric analysis of renal cell carcinoma].
    Lü GH
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometry of DNA in research on kidney tumors].
    Zubrikhina GN; Sokolova IN; Chistiakova OV
    Arkh Patol; 1989; 51(8):16-20. PubMed ID: 2554862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data.
    Cajulis RS; Katz RL; Dekmezian R; el-Naggar A; Ro JY
    Acta Cytol; 1993; 37(3):367-72. PubMed ID: 8498138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
    Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
    J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.
    El-Naggar AK; Kemp BL; Sneige N; Hurr KG; Steck K; Tu ZN; Fritsche HA; Singletary SE; Balch CM
    Clin Cancer Res; 1996 Feb; 2(2):419-26. PubMed ID: 9816186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.
    Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Passebosc-Faure K; Genin C; Tostain J
    In Vivo; 2002; 16(5):341-4. PubMed ID: 12494875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the 1 alpha, 25-dihydroxyvitamin D3 receptor concentration and the DNA content in renal cell carcinomas.
    Trydal T; Bakke A; Aksnes L; Aarskog D
    Anticancer Res; 1989; 9(6):1951-5. PubMed ID: 2560627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
    Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
    Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
    Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
    Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
    Tickoo SK; Amin MB; Linden MD; Zarbo RJ
    Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.